BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34115428)

  • 1. Oral mucositis in paediatric cancer patients undergoing allogeneic hematopoietic stem cell transplantation preventively treated with professional dental care and photobiomodulation: Incidence and risk factors.
    Miranda-Silva W; da Fonseca FP; Gomes AA; Mafra ABB; Rocha V; Fregnani ER
    Int J Paediatr Dent; 2022 Mar; 32(2):251-263. PubMed ID: 34115428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
    Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation.
    Nguyen DT; Shayani S; Palmer J; Dagis A; Forman SJ; Epstein J; Spielberger R
    Support Care Cancer; 2015 Nov; 23(11):3141-7. PubMed ID: 25791390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New photobiomodulation protocol prevents oral mucositis in hematopoietic stem cell transplantation recipients-a retrospective study.
    Weissheimer C; Curra M; Gregianin LJ; Daudt LE; Wagner VP; Martins MAT; Martins MD
    Lasers Med Sci; 2017 Dec; 32(9):2013-2021. PubMed ID: 28840382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive versus curative photobiomodulation for oral mucositis in patients with multiple myeloma undergoing hematopoietic stem cell transplantation: which approach is more effective?
    Rupel K; Cornacchia A; Poiani M; Mohamed S; De Bellis E; Ballerini M; Bogdan Preda TM; Poropat A; Di Lenarda R; Zaja F; Biasotto M; Ottaviani G
    Support Care Cancer; 2024 Mar; 32(3):208. PubMed ID: 38438625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation.
    Anand A; Anandi P; Jain NA; Lu K; Dunavin N; Hourigan CS; Le RQ; Chokshi PD; Ito S; Stroncek DF; Sabatino M; Barrett AJ; Battiwalla M
    Support Care Cancer; 2016 Feb; 24(2):815-822. PubMed ID: 26190358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients.
    Legert KG; Remberger M; Ringdén O; Heimdahl A; Dahllöf G
    Support Care Cancer; 2014 Aug; 22(8):2133-40. PubMed ID: 24647488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation.
    Shouval R; Kouniavski E; Fein J; Danylesko I; Shem-Tov N; Geva M; Yerushalmi R; Shimoni A; Nagler A
    Eur J Haematol; 2019 Oct; 103(4):402-409. PubMed ID: 31332836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic photobiomodulation therapy using 660 nm diode laser for oral mucositis in paediatric patients under chemotherapy: 5-year experience from a Brazilian referral service.
    Nunes LFM; de Arruda JAA; Souza AF; Silva RCC; Lanza CRM; Kakehasi FM; Mesquita RA; Abreu LG; Travassos DV; Silva TA
    Lasers Med Sci; 2020 Oct; 35(8):1857-1866. PubMed ID: 32535807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Mucositis Association with Periodontal Status: A Retrospective Analysis of 496 Patients Undergoing Hematopoietic Stem Cell Transplantation.
    Radochová V; Šembera M; Slezák R; Heneberk O; Radocha J
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoral versus extraoral photobiomodulation therapy in the prevention of oral mucositis in HSCT patients: a randomized, single-blind, controlled clinical trial.
    Ramos-Pinto MB; de Lima Gusmão TP; Schmidt-Filho J; Jaguar GC; Martins MD; Alves FA
    Support Care Cancer; 2021 Nov; 29(11):6495-6503. PubMed ID: 33905011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and efficacy of palifermin in prevention and management of oral mucositis in patients with acute lymphoblastic leukemia: a randomized, double-blind controlled clinical trial.
    Lucchese A; Matarese G; Manuelli M; Ciuffreda C; Bassani L; Isola G; Cordasco G; Gherlone E
    Minerva Stomatol; 2016 Feb; 65(1):43-50. PubMed ID: 26862696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of severe oral mucositis in patients undergoing different conditioning regimens in haematopoietic stem cell transplantation.
    Nakagaki M; Kennedy GA; Gavin NC; Clavarino A; Whitfield K
    Support Care Cancer; 2022 Nov; 30(11):9141-9149. PubMed ID: 36008731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photobiomodulation: a promising innovative approach for preventing oral mucositis in patients undergoing hematopoietic stem cell transplantation.
    Stocker N; Baltes V; Bellaiche S; Brouillard F; Belmoufid N; Rousseau C; Bonnin A; Van de Wyngaert Z; Ricard L; Banet A; Malard F; Duléry R; Mohty M; Brissot E
    Support Care Cancer; 2022 Oct; 30(10):8211-8216. PubMed ID: 35810217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary study in a new protocol for the treatment of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT).
    Vitale MC; Modaffari C; Decembrino N; Zhou FX; Zecca M; Defabianis P
    Lasers Med Sci; 2017 Aug; 32(6):1423-1428. PubMed ID: 28664389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and risk factors of oral mucositis in paediatric patients undergoing haematopoietic stem cell transplantation.
    Alhussain A; Alkhayal Z; Ayas M; Abed H
    Oral Dis; 2022 Apr; 28(3):657-669. PubMed ID: 33453145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: clinical outcomes in a context of specialized oral care using low-level laser therapy.
    Eduardo Fde P; Bezinelli LM; de Carvalho DL; Lopes RM; Fernandes JF; Brumatti M; Vince CS; de Azambuja AM; Vogel C; Hamerschlak N; Correa L
    Pediatr Transplant; 2015 May; 19(3):316-25. PubMed ID: 25677170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety of photobiomodulation therapy for oral mucositis in hematopoietic cell transplantation patients: a 15-year retrospective study.
    Bezinelli LM; Corrêa L; Vogel C; Kutner JM; Ribeiro AF; Hamerschlak N; Eduardo CP; Migliorati CA; Eduardo FP
    Support Care Cancer; 2021 Nov; 29(11):6891-6902. PubMed ID: 34021422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Window therapeutic of extraoral photobiomodulation for prevention of oral mucositis in HSCT patients: additional arm.
    da Cruz Santos LB; Ramos-Pinto MB; Zerbato RM; Ferreira MEMG; Schmidt-Filho J; Martins MD; Alves FA
    Support Care Cancer; 2023 Dec; 32(1):27. PubMed ID: 38097854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of a light therapy team to administer photobiomodulation therapy: A standardized protocol to prevent and treat oral mucositis in the pediatric hematopoietic stem cell transplant population.
    Magee K; Robins J; Staton S; Llaurador G; Stevens AM
    Pediatr Blood Cancer; 2024 Jun; 71(6):e30966. PubMed ID: 38556719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.